
17 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Cho, Pediatric Neurologist in Portland, OR?
Dr. Yoon-Jae Cho, MD is a Pediatric Neurologist, who primarily practices in Portland, OR. He has been practicing for over 17 years and is board certified. Dr. Cho is fluent in English, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Cho’s office at (503) 494-5856.
Where did Dr. Cho go to medical school and complete their residency?
Fellowship: Children's Hospital Boston, Boston, MA | Children's Hospital Boston MA
Is Dr. Cho board certified as a Pediatric Neurologist?
Yes, Dr. Yoon-Jae Cho, MD is board certified by the American Board of Psychiatry and Neurology since 2009
What languages does Dr. Cho speak?
Dr. Cho and their clinical team can communicate with patients in the following languages:
English
What conditions does a Pediatric Neurologist like Dr. Cho typically treat?
As a Pediatric Neurologist, conditions treated by Dr. Yoon-Jae Cho may include:
Please contact Dr. Cho's office directly to confirm care for your specific condition, for more information, or to schedule a consultation.
What procedures does a Pediatric Neurologist like Dr. Cho typically perform?
As a Pediatric Neurologist, procedures performed by Dr. Yoon-Jae Cho may include:
- Aging Brain (Neuropsychological Testing)
- Cortical Basal Ganglionic Degeneration (CBGD)
- Deep Brain Stimulation
- Disturbance of Skin Sensation
- Electroencephalogram (EEG)
- Evoked Potential Testing
- Gait Simulation
- Greater Occipital Nerve (GON) Block
Please contact Dr. Cho's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Cho accept my insurance?
Dr. Cho accepts most major insurance plans. Important: Please call our office at (503) 494-5856 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Cho accept in Portland, OR?
Dr. Cho in Portland, OR accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Blue Cross Blue Shield of Massachusetts
View All Insurances
Where is Dr. Cho's office located?
Dr. Yoon-Jae Cho's Primary Practice
3181 SW Sam Jackson Park Rd
Portland, OR 97239
(503) 494-5856
Recognitions
Awards
Faculty Development Award, Shore Fellowship Program for Scholars in Me
Young Investigator Award, Pediatric Brain Tumor Foundation
Laurel MD-PhD Scholar, Oregon Medical Research Foundation
Biology Committee, Pediatric Brain Tumor Consortium
Philip R. Dodge Young Investigator Award, Child Neurology Society
Beirne Faculty Scholar in Pediatirc Neuro-oncology, Stanford Universi
Scholar, St. Baldrick's Foundation
Publications
Epigenetic targeting of Hedgehog pathway transcriptiol output through BET bromodomain inhibition.
, 2014
Reduced H3K27me3 and D Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant
, 2013
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
, 2012
Integrative Genomic Alysis of Medullobl
, 2011
alpha 5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth
, 2014
Cytogenetic Prognostication Within Medulloblastoma Subgroups
, 2014
Genome Sequencing of SHH Medulloblastoma Predicts Genotype
, 2014
Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct
, 2014
BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma.
, 2014
Medulloblastoma Down Under 2013
, 2014
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.
, 2013
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular alysis.
, 2013
Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma.
, 2013
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.
, 2013
BAF complexes facilitate decatetion of D by topoisomerase IIa.
, 2013
Genomic alysis of diffuse pediatric low
, 2013
Inhibition of TWIST1 Leads to Activation of Oncogene-Induced Senescence in Oncogene
, 2013
Growth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 sigling
, 2013
Activation of ?-catenin/TCF targets following loss of the tumor suppressor SNF5.
The VEGF Pathway in Cancer and Disease: Responses, Resistance, and the Path Forward
, 2012
Medulloblastomics: the end of the beginning
, 2012
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
, 2012
Dissecting the genomic complexity underlying medulloblastoma
, 2012
Epigenetic ictivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors
, 2012
Twist1 Suppresses Senescence Programs and Thereby Accelerates and Maintains Mutant Kras
, 2012
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
, 2012
Molecular subgroups of medulloblastoma
, 2012
MicroR-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma
, 2012
Pleiotropic effects of miR-183 similar to 96 similar to 182 converge to regulate cell survival
, 2012
Molecular subgroups of medulloblastoma: the current consensus
, 2012
Biological and clinical heterogeneity of MYCN-amplified medulloblastoma
, 2012
Clol selection drives genetic divergence of metastatic medulloblastoma
, 2012
An Animal Model of MYC-Driven Medulloblastoma
, 2012
Expression of FoxM1 is required for the proliferation of medulloblastoma cells
, 2011
Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma
, 2011
Predicting Relapse in Patients With Medulloblastoma by Integrating Evidence From Clinical
, 2011
Molecular fingerprints of medulloblastoma and their application to clinical practice
, 2011
miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma
, 2011
Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences
, 2011
Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway
, 2010
Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma
, 2010
Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic Transformation
, 2010
The landscape of somatic copy-number alteration across human cancers
, 2010
MELATONIN DEFICIENCY AND DISRUPTED CIRCADIAN RHYTHMS IN PEDIATRIC SURVIVORS OF CRANIOPHARYNGIOMA
, 2009
Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability
, 2008